Northrop Grumman (NOC)

Cost of Revenue

$34.86B

TTM · Period ending: · USD

NOC logo

NOC Cost of Revenue

Latest reported$34.86B
NOC TTM Cost of Revenue ($0.00 → $34.86B)
High-resolution chart · PNG

NOC cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Northrop Grumman Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
34,862,000,000
34,288,000,000
33,674,000,000
33,641,000,000
32,979,000,000
32,673,000,000
32,559,000,000
32,671,000,000
34,070,000,000
33,914,000,000
33,423,000,000
32,739,000,000
30,795,000,000
30,214,000,000
29,520,000,000
29,128,000,000
28,007,000,000
27,640,000,000
27,906,000,000
28,399,000,000
29,433,000,000
29,890,000,000
29,840,000,000
29,321,000,000
27,814,000,000
27,319,000,000
26,987,000,000
26,582,000,000
26,454,000,000
25,796,000,000
24,627,000,000
23,304,000,000
22,038,000,000
20,964,000,000
20,261,000,000
19,849,000,000
19,548,000,000
19,199,000,000
18,928,000,000
18,731,000,000
18,189,000,000
18,044,000,000
17,903,000,000
17,884,000,000
18,159,000,000
18,272,000,000
18,459,000,000
18,378,000,000
18,553,000,000
18,679,000,000
18,956,000,000
19,282,000,000
19,369,000,000
19,570,000,000
19,584,000,000
19,638,000,000
19,793,000,000
20,029,000,000
20,272,000,000
20,786,000,000
22,720,000,000
24,710,000,000
26,887,000,000
28,609,000,000
27,986,000,000
28,101,000,000
28,291,000,000
28,130,000,000
29,075,000,000
28,597,000,000
28,092,000,000
27,698,000,000
27,554,000,000
27,059,000,000
26,395,000,000
25,821,000,000
25,232,000,000
25,002,000,000
24,796,000,000
24,742,000,000
24,570,000,000
24,802,000,000
25,288,000,000
25,590,000,000
25,727,000,000
25,622,000,000
25,263,000,000
25,109,000,000
24,645,000,000
23,998,000,000
23,401,000,000
22,322,000,000
20,175,000,000
18,035,000,000
15,937,000,000
14,360,000,000
13,976,000,000
13,625,000,000
13,057,000,000
11,219,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.